Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05735730

Can the Risk for AMD be Modulated?

Conditions: Age-Related Macular Degeneration (ARMD)

Sex: All
Ages: 55 Years – N/A
Phase: NA
Enrollment: 1800
Sponsor: Association for Innovation and Biomedical Research on Light and Image

Location: Portugal

Summary

The goal of this Cross-sectional, interventional study is to learn about whether different risk factors, as Mediterranean diet, lifestyle and concomitant medication can modulate the risk imprinted by genetics in Age-related macular degeneration (AMD). The main question it aims to answer is: How the genetic risk interacts with environmental and lifestyle factors, especially Mediterranean diet and chronic medication, in order to assess how this interplay protects or presents higher risk for the establishment or the progression of AMD.Participants:Vital Signs will be measured; Medical History, Demographics, Nutritional/lifestyle habits and Family History of AMD will be recorded; Ophthalmological Examination will be performed Genetic analysis will be performed.

Eligibility Criteria

Inclusion Criteria:Adult subjects (none of whom are vulnerable) who participated in the Epidemiologic Coimbra Eye Study (NCT01298674);Subjects capable of understanding the information about the study and to give their written informed consent to enter the study;Subjects willing and able to comply with the study proceduresExclusion Criteria:- No exclusion criteria apply.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05735730). StuddyBuddy aggregates publicly available trial information.